Online, direct-to-consumer access to insulin: patient safety considerations and reform

The online, direct-to-consumer (DTC) medical marketplace is proliferating more rapidly than regulation is evolving to ensure proper patient safety and public health controls. Along with this growing body of unrestrained medical testing and pharmaceuticals offered DTC online, most types of insulin an...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes science and technology 2012-11, Vol.6 (6), p.1503-1506
Main Authors: Lovett, Kimberly M, Liang, Bryan A, Mackey, Timothy K
Format: Article
Language:English
Subjects:
Advertising as Topic - ethics
Advertising as Topic - legislation & jurisprudence
Humans
Hypoglycemic Agents
Insulin
Patient Safety - legislation & jurisprudence
Pharmaceutical Services, Online - ethics
Pharmaceutical Services, Online - legislation & jurisprudence
Prescription Drug Misuse
Prescription Drugs
United States
United States Food and Drug Administration
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The online, direct-to-consumer (DTC) medical marketplace is proliferating more rapidly than regulation is evolving to ensure proper patient safety and public health controls. Along with this growing body of unrestrained medical testing and pharmaceuticals offered DTC online, most types of insulin and insulin administration products may now be purchased without prescriptions or physician guidance. Given the relatively significant risks of insulin use, the abuse potential, the high prevalence of diabetes mellitus, and the rising population of uninsured and underinsured, it is imperative to reform the online DTC medical marketplace to ensure that patient safety and public health are protected.
ISSN:1932-2968
1932-3107
DOI:10.1177/193229681200600632